Navigation Links
Osteoporosis drug stops growth of breast cancer cells, even in resistant tumors
Date:6/15/2013

use you are removing the target," said lead author Suzanne Wardell, PhD, a research scientist working in McDonnell's lab.

Many investigators had assumed that once breast cancer cells developed resistance to tamoxifen, they would be resistant to all drugs that target the estrogen receptor, McDonnell explained.

"We discovered that the estrogen receptor is still a good target, even after it resistance to tamoxifen has developed," he said.

The investigators tested a variety of breast cancer cell types, including tamoxifen-sensitive cells that are resistant to the drug lapatinib, another targeted therapy that is used to treat patients with advanced breast cancer whose tumors contain the mutant HER2 gene. These cells had previously been shown to reactivate estrogen signaling in order to acquire drug resistance. In this cell type, bazedoxifene also potently inhibited cell growth.

Paradoxically, in bone tissue, bazedoxifene mimics the action of estrogen, helping protect it from destruction. Because bazedoxifene has already undergone safety and efficacy studies as a treatment for osteoporosis, it may be a viable near-term option for patients with advanced breast cancer whose tumors have become resistant to other treatment options, Wardell reported. In clinical trials, the most often reported side effect was hot flashes in the bazedoxifene treatment groups.


'/>"/>

Contact: Rachel Harrison
rachel.harrison@duke.edu
919-419-5069
Duke University Medical Center
Source:Eurekalert

Page: 1 2

Related biology news :

1. IOF Worldwide Conference of Osteoporosis Patient Societies opens in Helsinki
2. Program announced for the 4th Asia-Pacific Osteoporosis Meeting in Hong Kong
3. Worlds largest meeting dedicated to osteoporosis and osteoarthritis opens in Rome
4. European Guidance for the diagnosis & management of osteoporosis in postmenopausal women
5. Less than 1 month to start of European Congress on Osteoporosis & Osteoarthritis in Rome
6. 4th Asia-Pacific Osteoporosis Meeting to be led by regions leading bone experts
7. European Congress on Osteoporosis and Osteoarthritis
8. Summit of osteoporosis experts from CIS countries issue 5-point call for action
9. IOF Asia-Pacific Meeting presents new research and advances in osteoporosis management
10. Launch of the EU large-scale integrating project BlueGenics to combat osteoporosis
11. Register now for the key osteoporosis meeting in the Asia-Pacific region
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... DIEGO, Calif. (August 19, 2014) Daylight was breaking ... MY Hanse Explorer. Between sips, about a dozen scientists ... and slip below the surface to collect water samples ... would tinker with the whirring gizmos and delicate machinery ... single goal: Be the first research group to bring ...
(Date:8/18/2014)... person,s gut may protect against or increase susceptibility to ... bacterial intestinal inflammation, according research published this week in ... American Society for Microbiology. The study also found that ... one,s gut bacteria composition. , "It has been known ... in the gut, can protect a person from colonization ...
(Date:8/18/2014)... UT Southwestern Medical Center have found a new way that ... known as long non-coding RNA. , The internal body clocks, ... functions, from waking and sleeping to body temperature and hunger. ... influenced by external cues such as light and temperature. , ... many organisms, what they do in the body, and how ...
Breaking Biology News(10 mins):Sequencing at sea 2Sequencing at sea 3What's in your gut? Certain bacteria may influence susceptibility to infection 2Researchers obtain key insights into how the internal body clock is tuned 2Researchers obtain key insights into how the internal body clock is tuned 3
... seeking to detect bioterrorism attacks, doctors diagnosing diseases ... a new ally in a Lawrence Livermore National ... as the Lawrence Livermore Microbial Detection Array (LLMDA), ... to detect within 24 hours any virus or ...
... prestigious Pierre Delmas Prize: An ESCEO-IOF/Servier Achievement Award was ... at the Claude Bernard University of Lyon, France. ... honour of the late Pierre D. Delmas, the world ... (IOF). The grant of 40,000 Euros, courtesy of Servier, ...
... A prescription drug already approved to treat genital warts and ... effectiveness of future vaccines for bacterial and viral diseases, such ... appear in ACS, Molecular Pharmaceutics , a bi-monthly journal. ... Research Center and UC-Berkeley note that vaccines prepared from weakened ...
Cached Biology News:New LLNL detection technology identifies bacteria, viruses, other organisms within 24 hours 2New LLNL detection technology identifies bacteria, viruses, other organisms within 24 hours 3Winner of Pierre Delmas Prize announced at World Congress on Osteoporosis 2010 2
(Date:8/18/2014)... 18, 2014 TNI BioTech, Inc. (OTC-BB: TNIB) ... manufacturing and marketing of innovative therapies for autoimmune diseases ... providing a second notice of TNI BioTech,s annual meeting ... announcement, Noreen Griffin , founder and CEO of ... your participation in the Annual Meeting. On behalf of ...
(Date:8/18/2014)... August 18, 2014 China is ... for the clinical research industry. Clinicaltrial.gov statistics highlight ... to its aging population; a high increase in ... a densely populated pool of patients and a ... these positive points, China also presents challenges for ...
(Date:8/16/2014)... 16, 2014 Firms in the ... guidance and advisory services to businesses, government bodies ... Industry services are highly diverse as operators assist ... range from geological and geophysical consulting services to ... the past five years, the recovery of the ...
(Date:8/16/2014)... make atomic-force microscope probes 20 times more sensitive and ... of an individual virus. , The technique, developed by ... using laser beams to cool a nanowire probe to ... achieved after cooling is accurate enough for us to ... 100 billion times lighter than a mosquito," said Dr ...
Breaking Biology Technology:TNI BioTech Inc., provides 2nd Notice of Annual Meeting September 4, 2014 2TNI BioTech Inc., provides 2nd Notice of Annual Meeting September 4, 2014 3TNI BioTech Inc., provides 2nd Notice of Annual Meeting September 4, 2014 4China – Land of Opportunities & Challenges for the Clinical Research Industry, New Webinar Hosted by Xtalks 2Scientific and Economic Consulting in Canada Industry Market Research Report Now Available from IBISWorld 2Scientific and Economic Consulting in Canada Industry Market Research Report Now Available from IBISWorld 3Laser makes microscopes way cooler 2
... Feb. 4 Art,s Way Manufacturing, Inc. (Nasdaq: ... subsidiary, Art,s Way Scientific, Inc. - Buildings For ... - http://www.buildingsforscience.com/ The new site, reflective ... enhanced, clean and more user-friendly.Art,s Way Scientific ( ...
... (Nasdaq: KNDL ) announced today that it will ... closes on Tuesday, Feb. 24, 2009. The Company will host ... 25 at 8:30 a.m. Eastern Time. A question and answer ... participate in the telephone conference call, interested parties in the ...
... Patients Achieved an Objective Tumor Response by End of ... Inc. (Nasdaq: PPHM ) today reported that ... endpoint in the first stage of its ongoing Phase ... cancer (NSCLC). The open-label, Simon two-stage study is ...
Cached Biology Technology:Art's Way Manufacturing Announces Launch of New Web Site For Art's Way Scientific - Buildings For Science 2Art's Way Manufacturing Announces Launch of New Web Site For Art's Way Scientific - Buildings For Science 3Kendle Announces Details Regarding Fourth Quarter and Full-Year 2008 Earnings and 2009 Guidance Release, Webcast and Conference Call 2Peregrine Pharmaceuticals' Bavituximab Achieves Primary Endpoint in First Stage of Phase II Lung Cancer Study 2Peregrine Pharmaceuticals' Bavituximab Achieves Primary Endpoint in First Stage of Phase II Lung Cancer Study 3Peregrine Pharmaceuticals' Bavituximab Achieves Primary Endpoint in First Stage of Phase II Lung Cancer Study 4
Normal human serum, single donor...
... Quality ISO 9001:2000 Certified ... All Precedures Validated, SOP's Training ... Process for All Procedures GLP Documentation Upon ... one stop shopping point for all your ...
Human IL-17D Affinity Purified Polyclonal Ab...
BBS/Glycerol/Casein Block and Diluent - 10X Concentrate, 1 L...
Biology Products: